Pasar al contenido principal

APRENDIZAJE PROFUNDO PARA LA DETECCION DE ANOMALIAS EN DATOS NO ESTRUCTURADOS

PID2021-127946OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A machine learning approach to identify groups of patients with hematological malignant disorders

  • Rodríguez-Belenguer, Pablo
  • Piñana, José Luis
  • Sánchez Montañés, Manuel
  • Soria Olivas, Emilio
  • Martínez Sober, Marcelino
  • Serrano López, Antonio J.
Background and objective: Vaccination against SARS-CoV-2 in immunocompromised patients with hematologic malignancies (HM) is crucial to reduce the severity of COVID-19. Despite vaccination efforts, over a third of HM patients remain unresponsive, increasing their risk of severe breakthrough infections. This study aims to leverage machine learning's adaptability to COVID-19 dynamics, efficiently selecting patient-specific features to enhance predictions and improve healthcare strategies. Highlighting the complex COVID-hematology connection, the focus is on interpretable machine learning to provide valuable insights to clinicians and biologists. Methods: The study evaluated a dataset with 1166 patients with hematological diseases. The output was the achievement or non-achievement of a serological response after full COVID-19 vaccination. Various machine learning methods were applied, with the best model selected based on metrics such as the Area Under the Curve (AUC), Sensitivity, Specificity, and Matthew Correlation Coefficient (MCC). Individual SHAP values were obtained for the best model, and Principal Component Analysis (PCA) was applied to these values. The patient profiles were then analyzed within identified clusters. Results: Support vector machine (SVM) emerged as the best-performing model. PCA applied to SVM-derived SHAP values resulted in four perfectly separated clusters. These clusters are characterized by the proportion of patients that generate antibodies (PPGA). Cluster 1, with the second-highest PPGA (69.91%), included patients with aggressive diseases and factors contributing to increased immunodeficiency. Cluster 2 had the lowest PPGA (33.3%), but the small sample size limited conclusive findings. Cluster 3, representing the majority of the population, exhibited a high rate of antibody generation (84.39%) and a better prognosis compared to cluster 1. Cluster 4, with a PPGA of 66.33%, included patients with B-cell non-Hodgkin's lymphoma on corticosteroid therapy. Conclusions: The methodology successfully identified four separate patient clusters using Machine Learning and Explainable AI (XAI). We then analyzed each cluster based on the percentage of HM patients who generated antibodies after COVID-19 vaccination. The study suggests the methodology's potential applicability to other diseases, highlighting the importance of interpretable ML in healthcare research and decision-making., We thank the Spanish Hematopoietic Transplant and Cell Therapy group (GETH-TC) for sharing the data. The co-author Manuel Sánchez-Montañés has been supported by grants PID2021-122347NB-I00 and PID2021-127946OB-I00 (funded by MCIN/AEI//10.13039/501100011033 and ERDF “A way of making Europe”), and from project FACINGLCOVID-CM under grant PD2022-004-REACT-EU.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Automatic artifact recognition and correction for electrodermal activity based on LSTM-CNN models

  • Llanes-Jurado, José
  • Lucia A. Carrasco-Ribelles
  • Soria-Olivas, Emilio
  • Alcañiz Raya, Mariano Luis|||0000-0001-9207-0636
  • Marín-Morales, Javier|||0000-0003-1271-2892
[EN] Researchers increasingly use electrodermal activity (EDA) to assess emotional states, developing novel appli-cations that include disorder recognition, adaptive therapy, and mental health monitoring systems. However, movement can produce major artifacts that affect EDA signals, especially in uncontrolled environments where users can freely walk and move their hands. This work develops a fully automatic pipeline for recognizing and correcting motion EDA artifacts, exploring the suitability of long short-term memory (LSTM) and convolutional neural networks (CNN). First, we constructed the EDABE dataset, collecting 74h EDA signals from 43 subjects collected during an immersive virtual reality task and manually corrected by two experts to provide a ground truth. The LSTM-1D CNN model produces the best performance recognizing 72% of artifacts with 88% accuracy, outperforming two state-of-the-art methods in sensitivity, AUC and kappa, in the test set. Subsequently, we developed a polynomial regression model to correct the detected artifacts automatically. Evaluation of the complete pipeline demonstrates that the automatically and manually corrected signals do not present differences in the phasic components, supporting their use in place of expert manual correction. In addition, the EDABE dataset represents the first public benchmark to compare the performance of EDA correction models. This work provides a pipeline to automatically correct EDA artifacts that can be used in uncontrolled conditions. This tool will allow to development of intelligent devices that recognize human emotional states without human intervention., This work was supported by the European Commission [RHUMBO H2020-MSCA-ITN-2018-813234] ; the Generalitat Valenciana, Spain [REBRAND PROMETEU/2019/105] ; the MCIN/AEI, Spain [PID2021-127946OB-I00] ; and the Universitat Politecnica de Valencia, Spain [PAID-10-20].
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A machine learning approach to identify groups of patients with hematological malignant disorders

  • Rodríguez-Belenguer, Pablo
  • Piñana, José Luis
  • Sánchez Montañés, Manuel
  • Soria Olivas, Emilio
  • Martínez Sober, Marcelino
  • Serrano López, Antonio J.
Background and objective: Vaccination against SARS-CoV-2 in immunocompromised patients with hematologic malignancies (HM) is crucial to reduce the severity of COVID-19. Despite vaccination efforts, over a third of HM patients remain unresponsive, increasing their risk of severe breakthrough infections. This study aims to leverage machine learning's adaptability to COVID-19 dynamics, efficiently selecting patient-specific features to enhance predictions and improve healthcare strategies. Highlighting the complex COVID-hematology connection, the focus is on interpretable machine learning to provide valuable insights to clinicians and biologists. Methods: The study evaluated a dataset with 1166 patients with hematological diseases. The output was the achievement or non-achievement of a serological response after full COVID-19 vaccination. Various machine learning methods were applied, with the best model selected based on metrics such as the Area Under the Curve (AUC), Sensitivity, Specificity, and Matthew Correlation Coefficient (MCC). Individual SHAP values were obtained for the best model, and Principal Component Analysis (PCA) was applied to these values. The patient profiles were then analyzed within identified clusters. Results: Support vector machine (SVM) emerged as the best-performing model. PCA applied to SVM-derived SHAP values resulted in four perfectly separated clusters. These clusters are characterized by the proportion of patients that generate antibodies (PPGA). Cluster 1, with the second-highest PPGA (69.91%), included patients with aggressive diseases and factors contributing to increased immunodeficiency. Cluster 2 had the lowest PPGA (33.3%), but the small sample size limited conclusive findings. Cluster 3, representing the majority of the population, exhibited a high rate of antibody generation (84.39%) and a better prognosis compared to cluster 1. Cluster 4, with a PPGA of 66.33%, included patients with B-cell non-Hodgkin's lymphoma on corticosteroid therapy. Conclusions: The methodology successfully identified four separate patient clusters using Machine Learning and Explainable AI (XAI). We then analyzed each cluster based on the percentage of HM patients who generated antibodies after COVID-19 vaccination. The study suggests the methodology's potential applicability to other diseases, highlighting the importance of interpretable ML in healthcare research and decision-making., We thank the Spanish Hematopoietic Transplant and Cell Therapy group (GETH-TC) for sharing the data. The co-author Manuel Sánchez-Montañés has been supported by grants PID2021-122347NB-I00 and PID2021-127946OB-I00 (funded by MCIN/AEI//10.13039/501100011033 and ERDF “A way of making Europe”), and from project FACINGLCOVID-CM under grant PD2022-004-REACT-EU.